Bipolar depression: pharmacotherapy and related therapeutic strategies
- 1 September 2000
- journal article
- review article
- Published by Elsevier in Biological Psychiatry
- Vol. 48 (6) , 558-572
- https://doi.org/10.1016/s0006-3223(00)00980-x
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Double-Blind, Placebo-Controlled Comparison of Imipramine and Paroxetine in the Treatment of Bipolar DepressionAmerican Journal of Psychiatry, 2001
- Bright Light TherapyThe Journal of Clinical Psychiatry, 1999
- Meta-Analysis of the Reversible Inhibitors of Monoamine Oxidase Type A Moclobemide and Brofaromine for the Treatment of DepressionPublished by Springer Nature ,1999
- Gabapentin Treatment of Mood DisordersThe Journal of Clinical Psychiatry, 1998
- Once-Versus Twice-Daily Venlafaxine Therapy in Major DepressionThe Journal of Clinical Psychiatry, 1998
- Do We Really Need All These New Antidepressants? Weighing the OptionsJournal of Psychiatric Practice, 1997
- Possible Monoamine Oxidase Inhibitor-Serotonin Uptake Inhibitor InteractionJournal of Clinical Psychopharmacology, 1993
- Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter studyJournal of Affective Disorders, 1993
- A review of the diagnostic status of “Bipolar II” for the DSM‐IV work group on mood disordersDepression, 1993
- Treatment strategy in depressionActa Psychiatrica Scandinavica, 1988